secwatch / observer

8-K filed June 14, 2023, 7:59 PM ET ticker BCYC CIK 0001761612

other material confidence high sentiment neutral materiality 0.10

Bicycle Therapeutics shareholders pass all 10 proposals at 2023 AGM

BICYCLE THERAPEUTICS PLC

Approximately 91.77% of outstanding ordinary shares voted; proposals passed with overwhelming support.
All three director nominees (Bourque, Jordan, Winter) re-elected; Winter received 27.2M votes for.
Advisory say-on-pay passed with 26.1M votes for vs. 1.97M against (93% approval).
PwC ratified as US auditor (28.0M for) and reappointed as UK statutory auditor.
Directors' remuneration policy approved with 26.1M for vs. 1.97M against (93% approval).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Janice Bourque. at the 2023-06-13 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 1 – To re-elect as a director Janice Bourque. For Against Vote Withheld/Abstain 27,895,136 154,479 7,306

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Veronica Jordan. at the 2023-06-13 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 2 – To re-elect as a director Veronica Jordan. For Against Vote Withheld/Abstain 27,943,943 105,672 7,306

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BICYCLE THERAPEUTICS PLC shareholders approved To receive and adopt the Company's U.K. statutory annual accounts and reports for the year ended December 31, 2022. at the 2023-06-13 meeting.

Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 8 – To receive and adopt the Company’s U.K. statutory annual accounts and reports for the year ended December 31, 2022. For Against Vote Withheld/Abstain 28,047,438 1,339 8,144

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BICYCLE THERAPEUTICS PLC shareholders approved To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement. at the 2023-06-13 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 4 – To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s definitive proxy statement. For Against Vote Withheld/Abstain 26,083,084 1,965,019 8,818

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Audit Committee to determine the Company's U.K. statutory auditors' remuneration for the year ending December 31, 2023. at the 2023-06-13 meeting.

Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 7 – To authorize the Audit Committee to determine the Company’s U.K. statutory auditors’ remuneration for the year ending December 31, 2023. For Against Vote Withheld/Abstain 28,047,978 1,381 7,562

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BICYCLE THERAPEUTICS PLC shareholders approved To approve the directors' remuneration report for the year ended December 31, 2022 (excluding the directors' remuneration policy). at the 2023-06-13 meeting.

Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 9 – To approve the directors’ remuneration report for the year ended December 31, 2022 (excluding the directors' remuneration policy). For Against Vote Withheld/Abstain 26,084,674 1,964,069 8,178

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Sir Greg Winter. at the 2023-06-13 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 3 – To re-elect as a director Sir Greg Winter. For Against Vote Withheld/Abstain 27,238,892 632,657 185,372

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BICYCLE THERAPEUTICS PLC shareholders approved To approve the directors' remuneration policy, which will take effect immediately after the end of the AGM. at the 2023-06-13 meeting.

Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 10 -– To approve the directors’ remuneration policy, which will take effect immediately after the end of the AGM. For Against Vote Withheld/Abstain 26,075,659 1,971,866 9,396

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BICYCLE THERAPEUTICS PLC shareholders approved To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. at the 2023-06-13 meeting.

Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 6 – To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. For Against Vote Withheld/Abstain 28,045,082 4,528 7,311

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BICYCLE THERAPEUTICS PLC shareholders approved To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2023. at the 2023-06-13 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 5 – To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2023. For Against Vote Withheld/Abstain 28,045,153 4,500 7,268

View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

BICYCLE THERAPEUTICS PLC filing history →

Source: SEC EDGAR

accession 0001104659-23-071024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.